Tibet Rhodiola Pharmaceutical Holding Co
SSE:600211
Tibet Rhodiola Pharmaceutical Holding Co
SSE:600211
Price:
39.15 CNY
1.16%
Market Closed
Updated:
May 14, 2024
Tibet Rhodiola Pharmaceutical Holding Co
Total Other Income
|
Tibet Rhodiola Pharmaceutical Holding Co
Total Other Income Peer Comparison
Comparables:
1099
601607
600998
C
600511
000963
Competitive Total Other Income Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Total Other Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Tibet Rhodiola Pharmaceutical Holding Co
SSE:600211
|
Total Other Income
-¥703.3k
|
CAGR 3-Years
27%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Sinopharm Group Co Ltd
HKEX:1099
|
Total Other Income
-¥169.2m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
0%
|
CAGR 10-Years
-6%
|
|
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
Total Other Income
-¥600.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Jointown Pharmaceutical Group Co Ltd
SSE:600998
|
Total Other Income
-¥9.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-3%
|
CAGR 10-Years
N/A
|
|
C
|
China National Medicines Corp Ltd
SSE:600511
|
Total Other Income
-¥13.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
2%
|
CAGR 10-Years
N/A
|
|
|
Huadong Medicine Co Ltd
SZSE:000963
|
Total Other Income
-¥28.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-3%
|
CAGR 10-Years
N/A
|
See Also
What is Tibet Rhodiola Pharmaceutical Holding Co's Total Other Income?
Total Other Income
-703.3k
CNY
-703.3k
CNY
Based on the financial report for Dec 31, 2023, Tibet Rhodiola Pharmaceutical Holding Co's Total Other Income amounts to -703.3k CNY.
What is Tibet Rhodiola Pharmaceutical Holding Co's Total Other Income growth rate?
Total Other Income CAGR 3Y
27%
27%
Over the last year, the Total Other Income growth was 32%. The average annual Total Other Income growth rates for Tibet Rhodiola Pharmaceutical Holding Co have been 27% over the past three years .
You don't have any saved screeners yet
